Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

HMGI(Y) gene expression as a potential marker of thyroid follicular carcinoma.

Czyz W, Balcerczak E, Jakubiak M, Pasieka Z, Kuzdak K, Mirowski M.

Langenbecks Arch Surg. 2004 Jun;389(3):193-7. Epub 2004 Apr 24.

PMID:
15107999
2.

Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.

Chiappetta G, Tallini G, De Biasio MC, Manfioletti G, Martinez-Tello FJ, Pentimalli F, de Nigris F, Mastro A, Botti G, Fedele M, Berger N, Santoro M, Giancotti V, Fusco A.

Cancer Res. 1998 Sep 15;58(18):4193-8.

3.

PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.

Lacroix L, Mian C, Barrier T, Talbot M, Caillou B, Schlumberger M, Bidart JM.

Eur J Endocrinol. 2004 Sep;151(3):367-74.

4.

Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.

Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, Elliott D, Clayman GL, El-Naggar AK.

Clin Cancer Res. 2004 Oct 1;10(19):6586-97.

5.

Involvement of the HMGI(Y) gene in a microfollicular adenoma of the thyroid.

Dal Cin P, Fusco A, Belge G, Chiappetta G, Fedele M, Pauwels P, Bullerdiek J, Van den Berghe H.

Genes Chromosomes Cancer. 1999 Mar;24(3):286-9.

PMID:
10451711
6.

Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.

Tabriz HM, Adabi Kh, Lashkari A, Heshmat R, Haghpanah V, Larijani B, Tavangar SM.

Pathol Res Pract. 2009;205(2):83-7. doi: 10.1016/j.prp.2008.08.007. Epub 2008 Nov 8.

PMID:
18996649
8.

Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors.

Arturi F, Russo D, Bidart JM, Scarpelli D, Schlumberger M, Filetti S.

Eur J Endocrinol. 2001 Aug;145(2):129-35.

9.

Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.

Belge G, Meyer A, Klemke M, Burchardt K, Stern C, Wosniok W, Loeschke S, Bullerdiek J.

Genes Chromosomes Cancer. 2008 Jan;47(1):56-63.

PMID:
17943974
10.

Expression of HMGI(Y) associated with malignant phenotype of human gastric tissue.

Nam ES, Kim DH, Cho SJ, Chae SW, Kim HY, Kim SM, Han JJ, Shin HS, Park YE.

Histopathology. 2003 May;42(5):466-71.

PMID:
12713623
11.

Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer.

Oji Y, Miyoshi Y, Koga S, Nakano Y, Ando A, Nakatsuka S, Ikeba A, Takahashi E, Sakaguchi N, Yokota A, Hosen N, Ikegame K, Kawakami M, Tsuboi A, Oka Y, Ogawa H, Aozasa K, Noguchi S, Sugiyama H.

Cancer Sci. 2003 Jul;94(7):606-11.

12.

Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.

Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A.

Surgery. 2005 Dec;138(6):1102-9; discussion 1109-10.

PMID:
16360397
13.

High mobility group HMGI(Y) protein expression in head and neck squamous cell carcinoma.

Rho YS, Lim YC, Park IS, Kim JH, Ahn HY, Cho SJ, Shin HS.

Acta Otolaryngol. 2007 Jan;127(1):76-81.

PMID:
17364334
14.

The natural protein kinase C alpha mutant is present in human thyroid neoplasms.

Prévostel C, Alvaro V, de Boisvilliers F, Martin A, Jaffiol C, Joubert D.

Oncogene. 1995 Aug 17;11(4):669-74.

PMID:
7651730
15.

Diagnostic significance of high mobility group I(Y) protein expression in intraductal papillary mucinous tumors of the pancreas.

Abe N, Watanabe T, Izumisato Y, Masaki T, Mori T, Sugiyama M, Chiappetta G, Fusco A, Fujioka Y, Atomi Y.

Pancreas. 2002 Aug;25(2):198-204.

PMID:
12142746
16.

Detection of mRNA of sodium iodide symporter in benign and malignant human thyroid tissues.

Liou MJ, Lin JD, Chan EC, Liu FH, Chao TC, Weng HF.

Cancer Lett. 2000 Nov 10;160(1):75-80.

PMID:
11098087
17.

Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.

Xu X, Quiros RM, Maxhimer JB, Jiang P, Marcinek R, Ain KB, Platt JL, Shen J, Gattuso P, Prinz RA.

Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5968-79.

18.

MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid.

Bièche I, Ruffet E, Zweibaum A, Vildé F, Lidereau R, Franc B.

Thyroid. 1997 Oct;7(5):725-31.

PMID:
9349575
19.

Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins.

Abe N, Watanabe T, Masaki T, Mori T, Sugiyama M, Uchimura H, Fujioka Y, Chiappetta G, Fusco A, Atomi Y.

Cancer Res. 2000 Jun 15;60(12):3117-22.

20.

The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias.

Chiappetta G, Bandiera A, Berlingieri MT, Visconti R, Manfioletti G, Battista S, Martinez-Tello FJ, Santoro M, Giancotti V, Fusco A.

Oncogene. 1995 Apr 6;10(7):1307-14.

PMID:
7731681
Items per page

Supplemental Content

Write to the Help Desk